Abediterol (LAS100977), a novel long-acting β2-agonist: efficacy, safety and tolerability in persistent asthma
about
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease.Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD.Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study.Next generation beta adrenoreceptor agonists for the treatment of asthma.Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD.
P2860
Abediterol (LAS100977), a novel long-acting β2-agonist: efficacy, safety and tolerability in persistent asthma
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@ast
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@en
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@nl
type
label
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@ast
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@en
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@nl
prefLabel
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@ast
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@en
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@nl
P2093
P3181
P1433
P1476
Abediterol (LAS100977), a nove ...... erability in persistent asthma
@en
P2093
G de Miquel
P304
P3181
P356
10.1016/J.RMED.2014.08.005
P407
P577
2014-10-01T00:00:00Z